Cargando…
Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV
Autores principales: | Moghe, Akshata, Barve, Shirish S., McClain, Craig J., Joshi-Barve, Swati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904047/ https://www.ncbi.nlm.nih.gov/pubmed/29693044 http://dx.doi.org/10.1016/j.jcmgh.2017.11.009 |
Ejemplares similares
-
Focus on the Liver: Alcohol Use, Highly Active Antiretroviral Therapy, and Liver Disease In HIV-Infected Patients
por: Barve, Shirish, et al.
Publicado: (2010) -
Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice
por: Chen, Wei-Yang, et al.
Publicado: (2016) -
cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease
por: Elnagdy, Mohamed, et al.
Publicado: (2020) -
Elevated Linoleic Acid (A Pro-Inflammatory PUFA) and Liver Injury in a Treatment Naive HIV-HCV Co-Infected Alcohol Dependent Patient
por: Vatsalya, Vatsalya, et al.
Publicado: (2016) -
Cytokines and Alcoholic Liver Disease
por: McClain, Craig J., et al.
Publicado: (1997)